coronavirus
encod
small
hydrophob
envelop
e
protein
mediat
viral
assembl
morphogenesi
unknown
mechan
previous
shown
e
protein
sever
acut
respiratori
syndrom
coronaviru
sarscov
form
cationselect
ion
channel
planar
lipid
bilay
wilson
l
mckinlay
c
gage
p
ewart
g
sar
coronaviru
e
protein
form
cationselect
ion
channel
virolog
report
three
e
protein
also
form
cationselect
ion
channel
e
protein
coronavirus
repres
taxonom
group
human
coronaviru
mous
hepat
viru
mhv
infecti
bronchiti
viru
ibv
respect
appear
therefor
coronaviru
e
protein
gener
belong
viru
ion
channel
famili
hexamethylen
amilorid
hma
inhibitor
vpu
viru
ion
channelinhibit
mhv
e
protein
ion
channel
conduct
bilay
also
inhibit
replic
parent
coronavirus
cultur
cell
determin
plaqu
assay
convers
hma
antivir
effect
recombin
mhv
entir
code
region
e
protein
delet
taken
togeth
data
provid
evid
link
inhibit
e
protein
ion
channel
activ
antivir
activ
hma
coronavirus
order
nidoviral
famili
coronavirida
genu
coronaviru
envelop
singlestrand
positivesens
rna
virus
genom
kb
coronavirus
encod
envelop
e
protein
small
hydrophob
membran
protein
exact
function
mechan
coronaviru
e
protein
yet
fulli
character
e
protein
shown
import
coronaviru
replic
role
viral
assembl
morphogenesi
fischer
et
al
kuo
master
ortego
et
al
gener
differ
coronaviru
e
protein
share
littl
sequenc
homolog
basic
structur
similar
shen
et
al
e
protein
small
hydrophob
protein
singl
put
transmembran
hydrophil
c
termin
domain
shen
et
al
siddel
previous
demonstr
e
protein
sever
acut
respiratori
syndrom
coronaviru
sarscov
form
cationselect
ion
channel
planar
lipid
bilay
select
na
k
ion
first
residu
sarscov
e
protein
encompass
put
transmembran
tm
domain
suffici
format
ion
channel
similar
properti
fulllength
peptid
first
coronaviru
e
protein
shown
belong
viru
ion
channel
famili
madan
et
al
recent
report
mhv
e
protein
induc
membran
permeabl
chang
e
coli
mammalian
membran
indic
viroporinlik
activ
madan
et
al
therefor
possibl
ion
channel
format
function
common
coronaviru
e
protein
yet
known
whether
sarscov
e
protein
ion
channel
activ
import
role
coronaviru
replic
howev
two
best
character
viru
ion
channel
protein
influenza
vpu
channel
activ
strongli
link
role
viru
life
cycl
studi
mutant
channel
block
drug
hout
et
al
hout
et
al
pinto
et
al
sakaguchi
et
al
schubert
et
al
ion
channel
activ
inhibit
amantadin
deriv
current
use
clinic
treatment
influenza
infect
fleme
pinto
et
al
demonstr
vpu
ion
channel
activ
planar
lipid
bilay
block
amilorid
deriv
hma
hma
also
inhibit
replic
cultur
human
macrophag
viral
ion
channel
inhibitor
also
discov
griffin
et
al
pavlov
et
al
premkumar
et
al
premkumar
et
al
although
evid
antivir
activ
compound
yet
publish
goal
research
therefor
identifi
coronaviru
e
protein
ion
channel
find
blocker
channel
activ
character
effect
channelblock
compound
viral
replic
paper
report
e
protein
three
coronaviruseshuman
coronaviru
group
coronaviru
mous
hepat
viru
mhv
group
infecti
bronchiti
viru
ibv
group
ion
channel
activ
planar
lipid
bilay
furthermor
mhv
e
protein
ion
channel
conduct
inhibit
amilorid
deriv
hma
amilorid
channelblock
activ
correl
inhibit
replic
virus
demonstr
plaqu
assay
convers
hma
antivir
activ
recombin
mhv
entir
e
protein
delet
indic
e
protein
possibl
antivir
target
synthet
peptid
correspond
e
protein
mhv
ibv
prepar
use
solid
phase
chemistri
fulllength
peptid
predict
molecular
weight
da
respect
excis
sdspolyacrylamid
gel
purifi
describ
materi
method
western
blot
analysi
purifi
peptid
fig
show
three
prepar
contain
discret
protein
band
electrophores
approxim
expect
size
fulllength
product
recogn
appropri
peptidespecif
antibodi
e
protein
ran
singl
discret
band
expect
molecular
weight
indic
sampl
contain
mostli
fulllength
protein
contain
significantli
truncat
product
mhvand
ibv
e
sampl
yield
discret
doublet
band
blot
case
smaller
two
band
run
expect
molecular
weight
possibl
due
highli
hydrophob
natur
protein
may
electropores
slowli
expect
may
larger
two
band
correspond
fulllength
least
near
fulllength
protein
smaller
band
repres
truncat
speci
mhv
e
protein
detect
antibodi
recogn
epitop
within
first
ntermin
amino
acid
refer
antimhv
en
sinc
peptid
synthesi
proce
cterminu
nterminu
would
requir
residu
form
epitop
react
antimhv
en
antibodi
western
blot
indic
smaller
immunoreact
peptid
would
truncat
nterminu
maxim
amino
acid
predict
mhv
e
protein
hydropathi
plot
e
protein
nterminu
consist
hydrophil
region
even
smaller
two
immunoreact
speci
would
contain
intact
tm
put
ion
channel
domain
ibv
e
protein
also
ran
doublet
like
larger
band
repres
fulllength
product
smaller
band
ibv
e
protein
sever
amino
acid
truncat
nterminu
three
synthet
peptid
western
blot
confirm
presenc
protein
least
suffici
length
contain
tm
put
ion
channelform
domain
e
protein
group
coronaviru
form
potassium
prefer
ion
channel
planar
lipid
bilay
addit
purifi
e
protein
ci
chamber
planar
lipid
bilay
rig
result
format
ion
channel
bilay
fig
show
typic
current
trace
solut
contain
gradient
nacl
mm
ci
mm
tran
rang
hold
potenti
fig
show
currentvoltag
iv
plot
experi
reveal
revers
potenti
mv
nineteen
similar
experi
theoret
equilibrium
potenti
na
ion
mv
averag
measur
revers
potenti
mv
mean
sem
indic
channel
weakli
select
na
ion
cl
ion
use
ion
activ
goldman
hodgkin
katz
ghk
equat
p
na
p
cl
ratio
calcul
indic
e
protein
ion
channel
time
permeabl
na
cl
ion
experi
averag
conduct
ps
maximum
conduct
measur
ps
fig
show
typic
current
trace
e
protein
asymmetr
kcl
solut
experi
k
ion
current
observ
revers
mv
fig
thirteen
compar
experi
theoret
k
equilibrium
potenti
mv
averag
measur
revers
potenti
mv
ghk
equat
e
protein
time
select
k
cl
ion
experi
averag
conduct
ps
ion
select
e
protein
ion
channel
thu
k
na
cl
channel
time
permeabl
k
na
ion
tabl
group
coronaviru
mhv
e
protein
form
ion
channel
sodium
select
mhv
e
protein
test
abil
form
ion
channel
planar
lipid
bilay
experi
done
determin
select
mhv
e
protein
na
ion
cl
ion
k
ion
cl
fig
show
characterist
current
trace
mhv
e
protein
ion
channel
activ
asymmetr
nacl
solut
experi
ion
current
revers
mv
fig
b
equival
experi
averag
revers
potenti
mv
close
na
equilibrium
potenti
mv
thu
mhv
e
protein
ion
channel
highli
select
na
ion
p
na
p
cl
ratio
experi
conduct
vari
ps
averag
conduct
ps
fig
illustr
repres
current
trace
mhv
e
protein
ion
channel
activ
concentr
gradient
kcl
experi
k
ion
flow
observ
revers
mv
fig
eleven
similar
experi
averag
revers
potenti
calcul
mv
indic
mhv
e
protein
ion
channel
time
select
k
cl
ion
conduct
experi
rang
ps
averag
ps
ion
select
order
mhv
e
protein
ion
channel
na
k
cl
channel
time
permeabl
na
k
ion
thu
mhv
e
protein
ion
channel
distinguish
monoval
cation
highli
select
na
ion
tabl
group
coronaviru
ibv
e
protein
form
ion
channel
prefer
sodium
ibv
e
protein
also
form
ion
channel
planar
lipid
bilay
experi
conduct
nacl
kcl
solut
demonstr
ibv
e
protein
channel
slight
prefer
na
ion
k
ion
similar
e
protein
channel
group
coronavirus
mhv
sarscov
fig
show
typic
current
trace
ibv
e
protein
ion
channel
conduct
asymmetr
nacl
solut
experi
na
ion
flow
observ
revers
mv
fig
independ
experi
averag
revers
potenti
mv
ibv
e
protein
p
na
p
cl
ratio
experi
conduct
variabl
highest
conduct
measur
ps
averag
conduct
ps
iv
relationship
ibv
e
protein
nacl
solut
nonlinear
indic
rectif
ion
channel
channel
conduct
smaller
tran
chamber
held
posit
potenti
rel
ci
chamber
polar
revers
typic
current
trace
ibv
e
protein
asymmetr
kcl
solut
shown
fig
iv
plot
indic
k
ion
flow
revers
mv
fig
equival
experi
averag
revers
potenti
mv
thu
ibv
e
protein
time
permeabl
k
cl
ion
averag
conduct
experi
ps
thu
ibv
e
protein
ion
select
seri
na
k
cl
channel
time
select
na
k
ion
tabl
rectif
ibv
e
protein
channel
seen
kcl
solut
current
explan
ibv
channel
show
rectif
na
k
solut
rectif
indic
ion
flow
readili
channel
one
direct
mechan
achiev
ibv
e
protein
channel
like
relat
specif
properti
protein
quaternari
structur
form
gate
select
filter
channel
vivo
signific
rectifi
channel
ion
conduct
occur
preferenti
one
direct
ie
extracellularintracellular
vice
versa
could
import
implic
physiolog
function
channel
previous
shown
ion
channel
conduct
planar
lipid
bilay
depend
addit
channelform
peptid
due
addit
solvent
buffer
alon
ewart
et
al
premkumar
et
al
wilson
et
al
demonstr
ion
channel
activ
observ
specif
due
mhv
e
protein
rather
contamin
sampl
purifi
epitopespecif
antibodi
recogn
protein
util
previous
publish
case
antibodi
shown
inhibit
ion
channel
activ
directli
bilay
experi
inhibit
depend
bind
antibodi
expos
epitop
either
physic
block
ion
channel
antibodi
induct
conform
chang
ion
channel
structur
inactiv
howev
mani
antibodi
simpl
bind
antibodi
may
suffici
inactiv
target
ion
channel
altern
antibodi
use
remov
ion
channelform
peptid
solut
ewart
et
al
melton
et
al
addit
affin
purifi
antibodi
recogn
ctermin
end
tm
domain
e
antibodi
ci
n
experi
tran
n
chamber
notic
reduc
e
protein
ion
channel
conduct
data
shown
howev
antibodi
use
remov
e
protein
solut
use
seiz
x
protein
immunoprecipit
kit
sampl
remain
solut
form
ion
channel
even
prolong
period
stir
min
n
result
shown
deplet
e
protein
sampl
confirm
western
blot
analysi
use
e
polyclon
antibodi
data
shown
contrast
sampl
contain
purifi
synthet
e
protein
alway
result
ion
channel
conduct
within
min
addit
peptid
ci
chamber
henc
immunoprecipit
experi
confirm
ion
channel
conduct
observ
addit
purifi
synthet
e
protein
planar
lipid
bilay
depend
presenc
fulllength
e
protein
case
mhv
e
protein
antibodi
direct
e
protein
first
amino
acid
nterminu
antimhv
en
antibodi
significantli
inhibit
ion
channel
conduct
ad
ci
chamber
p
n
test
test
differ
mean
data
confirm
channelform
speci
sampl
mhv
e
protein
fig
convers
addit
antimhv
en
antibodi
tran
chamber
affect
channel
conduct
fig
result
indic
mhv
e
protein
insert
bilay
orientationspecif
manner
ntermin
domain
face
ci
chamber
sinc
antimhv
en
antibodi
significantli
inhibit
mhv
e
protein
ion
channel
activ
confirm
ion
channelform
speci
contain
mhv
e
protein
nterminu
thu
like
fulllength
peptid
anoth
mhv
e
antibodi
antimhv
bind
directli
adjac
put
tm
domain
inhibit
mhv
e
protein
ion
channel
conduct
ad
ci
n
tran
chamber
n
fig
howev
similarli
e
protein
antimhv
antibodi
use
immunoprecipit
fulllength
mhv
e
protein
solut
western
blot
analysi
immunoprecipit
flowthrough
demonstr
mhv
e
protein
remov
solut
data
shown
addit
mhv
e
deplet
solut
ci
chamber
result
ion
channel
format
planar
lipid
bilay
n
experi
even
stir
h
min
data
demonstr
ion
channel
conduct
detect
specif
due
purifi
fulllength
mhv
e
protein
unfortun
abl
obtain
enough
antiibv
e
protein
antiserum
conduct
ion
channel
inhibit
immunoprecipit
experi
ibv
e
protein
nevertheless
antiibv
e
antibodi
direct
ctermin
use
demonstr
synthet
purifi
ibv
e
protein
contain
fulllength
peptid
fig
test
amilorid
plu
deriv
hma
abil
inhibit
mhv
ibv
e
protein
ion
channel
planar
lipid
bilay
ion
channel
conduct
detect
compound
ad
ci
chamber
stir
facilit
bind
compound
channel
fig
demonstr
hma
significantli
reduc
e
protein
p
n
mhv
e
protein
p
n
current
across
bilay
hma
signific
affect
ibv
e
protein
channel
conduct
p
n
amilorid
signific
effect
coronaviru
e
protein
ion
channel
activ
data
shown
furthermor
addit
compound
solvent
dmso
methanol
alon
affect
e
protein
ion
channel
conduct
data
shown
indic
channel
inhibit
depend
presenc
hma
determin
hma
inhibit
mhv
e
protein
dosedepend
manner
hma
titrat
mhv
e
protein
channel
activ
planar
lipid
bilay
fig
demonstr
increas
concentr
hma
subsequ
decreas
channel
activ
percent
inhibit
plot
concentr
hma
equat
line
effect
concentr
ec
hma
mhv
e
protein
channel
activ
bilay
calcul
data
confirm
inhibit
observ
hma
specif
due
addit
compound
spontan
reduct
channel
macroscop
conduct
occasion
channel
activ
bilay
go
quiet
absenc
inhibitor
could
due
lipid
encompass
peptid
reduct
macroscop
channel
activ
open
probabl
spontan
reduct
channel
activ
would
occur
linear
dosedepend
fashion
observ
fig
determin
amilorid
hma
inhibit
mhv
replic
cultur
cell
test
abil
reduc
number
mhv
plaqu
cell
without
plaqu
overlay
mhv
infect
cell
without
plaqu
overlay
result
newli
emerg
viru
diffus
origin
infect
cell
start
new
plaqu
therefor
presenc
antivir
compound
reduct
plaqu
number
cell
infect
mhv
multipl
infect
moi
treat
variou
concentr
hma
amilorid
see
materi
method
number
plaqu
per
well
count
percent
reduct
plaqu
number
calcul
compound
control
percent
reduct
plot
compound
concentr
ec
calcul
equat
line
ec
hma
mhv
replic
calcul
tabl
reason
agreement
ec
measur
bilay
experi
amilorid
inhibit
mhv
replic
cultur
cell
tabl
correl
inabl
amilorid
inhibit
ion
channel
activ
bilay
investig
plaqu
phenotyp
mhv
presenc
hma
cell
plaqu
overlay
use
plaqu
overlay
mhv
infect
cell
slow
diffus
newli
emerg
viru
infect
adjac
cell
result
larger
plaqu
cell
hma
test
mhv
infect
cell
significantli
ec
measur
cell
tabl
remov
toxic
determin
mtt
cytotox
assay
determin
mhv
e
protein
antivir
target
hma
also
test
abil
inhibit
recombin
mhv
entir
e
protein
delet
replic
low
titer
small
plaqu
phenotyp
cell
kuo
master
therefor
expect
compound
target
mhv
e
protein
replic
would
affect
furthermor
hma
target
mhv
e
protein
plaqu
phenotyp
mhv
wildtyp
presenc
hma
would
compar
small
plaqu
phenotyp
fig
show
mhv
wildtyp
viru
mous
cell
larg
plaqu
phenotyp
mm
diamet
absenc
antivir
compound
fig
presenc
hma
plaqu
size
reduc
mm
fig
size
plaqu
fig
convers
amilorid
reduc
mhv
plaqu
size
fig
moreov
none
amilorid
deriv
test
notabl
inhibit
plaqu
format
fig
indic
mhv
e
protein
probabl
antivir
target
hma
block
e
protein
ion
channel
conduct
planar
lipid
bilay
also
inhibit
replic
cultur
cell
fig
ec
hma
calcul
tabl
addit
amilorid
block
e
protein
ion
channel
current
amplitud
antivir
activ
replic
cultur
cell
fig
previous
report
sarscov
e
protein
member
viral
ion
channel
famili
paper
extend
list
known
coronaviru
ion
channel
three
data
demonstr
e
protein
mhv
ibvrepres
coronaviru
taxonom
group
respectivelyform
cationselect
ion
channel
planar
lipid
bilay
case
mhv
epitopespecif
antibodi
use
confirm
channelform
speci
test
sampl
inde
purifi
synthet
e
protein
e
antibodi
bind
ctermin
side
transmembran
helix
inhibit
channel
activ
bilay
howev
antibodi
use
immunoprecipit
e
protein
residu
supernat
form
ion
channel
antimhv
en
antibodi
inhibit
mhv
e
ion
channel
activ
ad
one
chamber
bilay
rig
indic
nterminu
peptid
expos
ci
side
bilay
show
peptid
align
parallel
rather
antiparallel
conform
presum
homooligom
form
ion
channel
herein
also
show
hma
inhibit
ion
channel
form
mhv
e
protein
see
fig
hma
amilorid
analogu
also
block
viral
ion
channel
includ
vpu
ewart
et
al
hepat
c
viru
hcv
premkumar
et
al
protein
dengu
premkumar
et
al
broadspectrum
inhibit
hma
suggest
drugbind
site
channel
divers
virus
share
structur
similar
anoth
exampl
one
compound
inhibit
differ
ion
channel
amantadin
block
influenza
pinto
et
al
sugru
hay
hcv
griffin
et
al
dengu
protein
channel
premkumar
et
al
hma
block
ibv
e
protein
ion
channel
suggest
diverg
structur
group
coronaviru
e
protein
regard
model
membran
topolog
ibv
mhv
e
protein
quit
differ
cors
macham
maeda
et
al
rectifi
iv
plot
observ
nacl
solut
fig
also
indic
uniqu
properti
ibv
e
protein
channel
warrant
investig
viral
ion
channel
like
influenza
vpu
ion
channel
activ
known
import
viru
replic
review
fischer
sansom
gonzalez
carrasco
amantadin
clinic
use
influenza
infect
clearest
evid
mechan
action
channel
viru
replic
well
character
shown
hmaa
blocker
vpu
ion
channelinhibit
replic
cultur
human
primari
macrophag
case
underli
mechanist
link
remain
uncov
manuscript
report
addit
block
e
protein
ion
channel
hma
also
inhibit
replic
mhv
convers
hma
inhibit
recombin
viru
entir
e
protein
delet
see
taken
togeth
data
impli
antivir
target
hma
e
protein
e
protein
ion
channel
activ
import
coronaviru
replic
group
previous
provid
evid
import
e
protein
replic
mhv
transmiss
gastroenter
coronaviru
tgev
group
coronaviru
kuo
master
ortego
et
al
delet
open
read
frame
encod
e
protein
genom
mhv
result
strongli
attenu
viru
small
plaqu
phenotyp
kuo
master
indic
e
protein
import
role
mhv
life
cycl
essenti
vitro
replic
mhv
contrast
e
gene
thought
essenti
replic
tgev
ortego
et
al
hma
inhibit
mhv
replic
cultur
cell
ec
ec
hma
mhv
e
protein
ion
channel
activ
planar
lipid
bilay
calcul
two
ec
good
agreement
particularli
given
vast
differ
physicochem
environ
channel
expos
bilay
compar
infect
cell
fact
membran
insert
channel
assembl
regul
natur
process
artifici
bilay
e
protein
channel
describ
differ
ion
select
see
tabl
e
protein
test
hitherto
prefer
monoval
cation
chlorid
ion
channel
form
e
protein
group
coronaviru
four
time
select
k
na
channel
mhv
group
ibv
group
prefer
na
ion
two
e
protein
group
coronavirus
test
thu
far
mhv
sarscov
subgroup
respect
similar
highest
select
sodium
other
previous
note
rel
high
degre
amino
acid
sequenc
similar
mhv
sarscov
e
protein
especi
tm
domain
shen
et
al
e
protein
channel
character
interest
see
channel
properti
vari
sequenc
diverg
whether
ion
select
properti
cosegreg
taxonom
group
complement
studi
suggest
e
protein
coronaviru
group
may
function
similar
group
e
protein
recombin
mhv
group
construct
ibv
e
protein
group
well
group
e
protein
bovin
coronaviru
sarscovcould
substitut
mhv
e
protein
enhanc
replic
recombin
virus
hand
tgev
group
e
protein
could
function
replac
mhv
e
protein
lili
kuo
paul
master
person
commun
similar
experi
group
group
e
protein
abl
substitut
format
heterolog
viruslik
particl
vlp
baudoux
et
al
possibl
function
similar
differ
may
relat
ion
channel
select
e
protein
channel
found
similar
group
e
channel
prefer
na
ion
group
prefer
k
ion
cours
ion
channel
select
complement
studi
requir
confirm
earli
observ
summari
data
present
demonstr
coronaviru
e
protein
belong
grow
famili
viru
ion
channel
hma
block
mhv
e
protein
channel
correl
abil
inhibit
coronaviru
replic
cultur
cell
convers
hma
affect
recombin
viru
replic
cultur
cell
taken
togeth
data
suggest
e
protein
ion
channel
activ
import
coronaviru
replic
e
protein
blocker
could
potenti
anticoronavir
therapeut
use
peptid
synthes
correspond
e
protein
sequenc
three
coronavirus
genbank
databas
tabl
peptid
synthes
biomolecular
research
facil
john
curtin
school
medic
research
symphonymultiplex
protein
technolog
inc
woburn
ms
multipl
peptid
synthes
use
fmoc
chemistri
solid
phase
peptid
synthesi
fulllength
peptid
purifi
truncat
product
use
proteoplu
kit
qbiogen
inc
ca
follow
manufactur
instruct
briefli
e
peptid
dissolv
load
buffer
mm
trishcl
ph
urea
sd
glycerol
bromophenol
blue
mm
approxim
e
peptid
run
molecular
weight
marker
mbi
fermenta
hanov
md
gradient
polyacrylamid
gel
gradipor
nsw
australia
band
correspond
fulllength
peptid
kda
mhv
ibv
e
protein
respect
excis
gel
place
proteoplu
tube
subject
electrophoresi
purifi
peptid
dri
speedyvac
resuspend
tfe
peptid
concentr
determin
bradford
assay
pierc
rockford
il
follow
manufactur
instruct
attempt
character
purifi
e
peptid
mass
spectrometri
unsuccess
possibl
due
hydrophob
natur
peptid
three
synthet
peptid
also
made
product
antibodi
recogn
mhv
e
protein
sequenc
shorter
peptid
indic
underlin
boldfac
segment
fulllength
sequenc
tabl
antigen
peptid
chemic
synthes
coupl
polylysin
core
via
termin
cystein
prepar
multipl
antigen
peptid
map
lu
et
al
individu
new
zealand
white
rabbit
immun
map
conjug
peptid
initi
immun
peptid
freund
complet
adjuv
pierc
rockford
il
booster
peptid
given
everi
week
freund
incomplet
adjuv
pierc
rockford
il
suffici
antibodi
titer
attain
ml
blood
collect
ear
vein
week
postimmun
antisera
prepar
antiserum
assay
antibodi
product
western
blot
appropri
fulllength
e
peptid
epitopespecif
antibodi
purifi
antisera
column
coupl
equival
peptid
pierc
rockford
il
follow
manufactur
instruct
western
blot
analysi
sampl
prepar
load
buffer
mm
trishcl
ph
urea
sd
glycerol
bromophenol
blue
mm
run
molecular
weight
marker
mbi
fermenta
hanov
md
gradient
polyacrylamid
gel
gradipor
nsw
australia
peptid
transfer
polyvinyliden
difluorid
membran
invitrogen
vic
australia
use
semidri
transfer
apparatu
amersham
bioscienc
vic
australia
nonspecif
site
block
skim
milk
protein
trisbuff
salin
contain
peptid
detect
purifi
primari
antibodi
e
protein
tm
domain
ctermin
e
mhv
e
protein
ntermin
antibodi
antimhv
en
ibv
e
protein
antictermin
antibodi
antiibv
ec
cors
macham
kind
gift
carolyn
macham
john
hopkin
univers
baltimor
primari
antibodi
detect
goat
antirabbit
igg
alkalin
phosphataseconjug
antibodi
dako
nsw
color
develop
visual
western
bluestabil
substrat
alkalin
phosphatas
promega
nsw
australia
purifi
mhv
ibv
e
protein
resuspend
mgml
tfe
abil
form
ion
channel
test
warner
bilay
rig
warner
instrument
inc
dixwel
avenu
hamden
ct
describ
previous
briefli
lipid
mix
phosphatidyl
phosphatidyl
phosphatidyl
cholin
chloroform
dri
n
ga
resuspend
ndecan
bilay
paint
across
circular
hole
approxim
diamet
delrin
cup
separ
aqueou
solut
ci
tran
chamber
test
e
protein
select
na
cl
ion
solut
ci
chamber
consist
mm
nacl
mm
hepe
ph
solut
tran
chamber
contain
mm
nacl
mm
hepe
ph
test
e
protein
select
k
cl
ion
solut
ci
chamber
consist
mm
kcl
mm
hepe
ph
solut
tran
chamber
contain
mm
kcl
mm
hepe
ph
current
amplifi
use
warner
model
amplifi
sampl
rate
khz
filter
khz
digit
record
directli
use
small
aliquot
e
peptid
dissolv
tfe
ad
ci
chamber
stir
facilit
spontan
insert
hydrophob
peptid
lipid
bilay
typic
present
ion
channel
activ
detect
min
stir
ci
chamber
earth
tran
chamber
held
rang
potenti
mv
mv
voltag
v
vs
current
plot
iv
plot
determin
revers
potenti
v
r
indic
ion
select
channel
theoret
v
r
na
k
select
channel
experiment
set
mv
wherea
theoret
v
r
cl
channel
mv
use
activ
nernst
equat
v
r
use
goldmanhodgkinkatz
ghk
equat
determin
rel
permeabl
ratio
p
na
p
cl
p
k
p
cl
ion
channel
determin
antibodi
block
ion
channel
activ
detect
affinitypurifi
polyclon
antibodi
ad
ci
tran
chamber
final
concentr
stir
bilay
current
record
ion
channel
format
ion
channel
format
addit
purifi
antibodi
test
microsoft
excel
use
determin
signific
differ
mean
current
record
addit
epitopespecif
antibodi
affin
purifi
e
antimhv
antibodi
use
immunoprecipit
mhv
e
protein
respect
use
seiz
x
protein
immunoprecipit
kit
pierc
rockford
il
follow
manufactur
instruct
briefli
antibodi
bound
crosslink
protein
column
mgml
correspond
e
protein
immunoprecipit
solut
flowthrough
contain
e
protein
eluat
contain
immunoprecipit
e
protein
analyz
western
blot
mhv
e
protein
flowthrough
test
abil
form
ion
channel
planar
lipid
bilay
describ
stock
solut
amilorid
hma
sigma
australia
mm
prepar
methanol
determin
amilorid
deriv
block
e
protein
ion
channel
conduct
planar
lipid
bilay
ion
channel
current
detect
compound
ad
ci
chamber
stir
facilit
bind
compound
channel
current
across
bilay
record
prior
addit
e
protein
detect
ion
channel
conduct
addit
compound
test
microsoft
excel
use
test
differ
normal
mean
current
addit
compound
mous
cell
line
atcc
grown
dmem
invitrogen
vic
australia
supplement
fc
invitrogen
vic
australia
atcc
mhv
entir
e
protein
delet
refer
kind
gift
paul
master
wadsworth
centr
albani
amplifi
cell
mhv
wildtyp
recombin
viru
plaqu
assay
cell
plaqu
overlay
observ
plaqu
phenotyp
assay
cell
without
overlay
easi
count
plaqu
number
human
cell
line
atcc
grown
dmem
invitrogen
vic
australia
supplement
fc
invitrogen
vic
australia
atcc
two
time
plaqu
purifi
cell
plaqu
assay
cell
plaqu
overlay
determin
hma
amilorid
antivir
activ
mhv
calcul
compound
ec
plaqu
assay
done
cell
without
plaqu
overlay
mhv
infect
cell
without
plaqu
overlay
result
newli
emerg
plaqu
dissemin
origin
infect
cell
start
new
plaqu
therefor
presenc
antivir
compound
reduct
plaqu
number
easili
count
cell
infect
mhv
wildtyp
multipl
infect
moi
h
co
amilorid
hma
ad
incub
co
cultur
media
remov
cell
stain
crystal
violet
methanol
plaqu
number
per
well
count
percent
reduct
calcul
compound
control
compound
concentr
plot
percent
reduct
plaqu
ec
calcul
equat
line
plaqu
phenotyp
mhv
wildtyp
presenc
absenc
antivir
compound
studi
mous
cell
plaqu
overlay
seaplaqu
mem
fc
cell
plate
plate
grown
confluenc
infect
mhv
wildtyp
moi
moi
h
higher
moi
use
number
plaqu
per
well
compar
mhv
wildtyp
lower
titrat
incub
viru
remov
replac
seaplaqu
overlay
mem
supplement
fc
compound
control
testantivir
compound
dissolv
dmso
methanol
incub
co
cell
stain
crystal
violet
methanol
averag
plaqu
size
determin
plaqu
assay
human
cell
cell
grown
confluenc
plate
infect
moi
h
co
incub
compound
control
testantivir
compound
dissolv
dmso
methanol
ad
well
assay
incub
day
co
plaqu
visibl
stain
crystal
violet
methanol
concentr
compound
use
antivir
assay
significantli
toxic
determin
mtt
cytotox
assay
sigma
australia
follow
manufactur
instruct
note
cell
compound
found
consider
toxic
like
due
elong
natur
result
greater
absorb
compound
therefor
amilorid
deriv
plaqu
assay
use
lower
concentr
toxic
cell
